NCI - Surgery Branch [clinicaltrials_resource:685f356afeaa45faa15a00e9968116f7]
Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00085462]Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00091104]clinicaltrials:NCT00096382Cyclophosphamide and Fludarabine Followed By an Autologous Lymphocyte Infusion and Interleukin-2 in Treating Patients With Refractory or Recurrent Metastatic Melanoma [clinicaltrials:NCT00138229]LMB-2 Immunotoxin and Vaccine Therapy in Treating Patients With Metastatic Melanoma That Cannot Be Removed By Surgery [clinicaltrials:NCT00295958]TNF-Bound Colloidal Gold in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00356980]
location [clinicaltrials_vocabulary:location]
NCI - Surgery Branch [clinicaltrials_resource:685f356afeaa45faa15a00e9968116f7]
Bio2RDF identifier
685f356afeaa45faa15a00e9968116f7
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:685f356afeaa45faa15a00e9968116f7
address [clinicaltrials_vocabulary:address]
identifier
clinicaltrials_resource:685f356afeaa45faa15a00e9968116f7
title
NCI - Surgery Branch
@en
type
label
NCI - Surgery Branch [clinicaltrials_resource:685f356afeaa45faa15a00e9968116f7]
@en